Head/Neck Cancer

Top Story

American Cancer Society creates blueprint to reduce cancer mortality by 2035

American Cancer Society creates blueprint to reduce cancer mortality by 2035
July 10, 2018
In the Journals Plus

Nivolumab shows antitumor activity in nasopharyngeal carcinoma

July 6, 2018
Nivolumab showed promising clinical activity among patients with pretreated recurrent or metastatic nasopharyngeal carcinoma, according to data published in Journal of
In the Journals

Parents support HPV vaccination to prevent cancer, not STDs, in their teens

June 27, 2018
“Although our study focused on starting the HPV vaccine series vs. continuing it or completing it, completion is a concern. An MMWR found that by 2016, 60% of…
In the Journals Plus

Rivaroxaban reduces VTE recurrence in patients with cancer

June 27, 2018
Rivaroxaban significantly reduced venous thromboembolism recurrence among patients who had cancer and VTE compared with dalteparin, according to findings published in…
More Headlines »
CME CNE CPE

Immune Checkpoint Inhibitors for Genitourinary Cancers: Practice Essential for Community Oncologists and Advanced Practice Providers

This activity is supported by an educational grant from Merck & Co., Inc.

For many years, the mainstay of initial treatment for metastatic bladder cancer has been chemotherapy. However…
More »
Video

Baseball great Mike Schmidt became ‘concerned about dying’ after melanoma diagnosis

September 25, 2017
More »
Resource Centers
ASCO Annual Meeting

ASCO Annual Meeting

CME

Virtual NSCLC: Updates in Combining Immunotherapy with Other Treatment Modalities

This activity is supported by an educational grant from Merck & Co., Inc.

Lung cancer is a leading cause of cancer death worldwide. The American Cancer Society estimates that there will be…
More »